Drugs / Penicillin
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | PENICILLIN | — | 1964-05-27 | fda.gov ↗ |
Trials 8
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00001359 | Apr 1993 → Jan 2006 | obsessive-compulsive disorder, streptococcal infection, tic disorder | National Institute of Mental Health (NIMH) | Completed | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT00315042 | Mar → Aug 2006 | pharyngitis, tonsillitis | Sanofi | Terminated | No outcome recorded |
| Phase 3 | NCT00315549 | Feb → Sep 2006 | pharyngitis, tonsillitis | Sanofi | Terminated | No outcome recorded |
| Phase 3 | NCT00000585 | Aug 1983 → Oct 1994 | pneumococcal infection, pneumonia, sickle cell disease | National Heart, Lung, and Blood Institute (NHLBI) | Completed | No outcome recorded |
| Phase 43 trials | ||||||
| Phase 4 | NCT01247909 | Apr 2010 → Feb 2015 | bacterial meningitis | Kamuzu University of Health Sciences | Completed | No outcome recorded |
| Phase 4 | NCT00261742 | Oct 2005 → Dec 2006 | streptococcal infection | University Children's Hospital Basel | Terminated | No outcome recorded |
| Phase 4 | NCT00363688 | Jan 1998 → May 2004 | hypersensitivity reaction disease | Meir Medical Center | Terminated | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT06192277 | Oct 2023 → Sep 2024 | — | Northern Ontario School of Medicine | Unknown | No outcome recorded |
| Comparator or background therapy6 trials | ||||||
| Phase 4 | NCT07845812 Comparator | Sep 2026 → Apr 2029 expected | streptococcal sore throat | The University of Texas Health Science Center, Houston | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06712641 Comparator | Apr 2026 → Jun 2028 expected | infectious disease with sepsis | University Hospital, Akershus | Recruiting | No outcome recorded |
| Phase 4 | NCT05977868 Comparator | Aug 2023 → Feb 2025 | digestive system infectious disorder | West Virginia University | Terminated | No outcome recorded |
| — | NCT01255670 Comparator | Feb 2010 → Apr 2011 | peritonsillar abscess | Helsinki University Central Hospital | Completed | No outcome recorded |
| — | NCT00844337 Comparator | Mar 2009 → Sep 2013 | infectious disease with sepsis | Johns Hopkins Bloomberg School of Public Health | Completed | No outcome recorded |
| — | NCT00405158 Background | Jan 2002 → Mar 2004 | mastitis | Karlstad University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 14 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Penicillin | “Empirical therapy for suspected community-acquired sepsis with gentamicin + narrow spectrum betalactam (either one of penicillin, ampicillin, or cloxacillin)” NCT06712641 ↗13“meropenem, oritavancin, oxacillin, penicillin, piperacillin-tazobactam, tigecycline, vancomycin” NCT05977868 ↗ “Participants will receive oral penicillin or amoxicillin for 5 days” NCT07845812 ↗ |
| Route | Oral | “regular daily administration of oral penicillin” NCT00000585 ↗ |